Technical Analysis for MYOK - MyoKardia, Inc.

Grade Last Price % Change Price Change
grade C 49.8 0.34% 0.17
MYOK closed down 0.48 percent on Monday, May 20, 2019, on 49 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MYOK trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.83%
Spinning Top Other 0.83%
Bollinger Band Squeeze Range Contraction 0.83%
NR7 Range Contraction 0.83%
Multiple of Ten Bearish Other 0.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.34%
20 DMA Support Bullish 0.34%
Bollinger Band Squeeze Range Contraction 0.34%
Up 3 Days in a Row Strength 0.34%
Up 4 Days in a Row Strength 0.34%

Older signals for MYOK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
MyoKardia, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a product candidate that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. MyoKardia, Inc. has a strategic collaboration with Sanofi S.A. The company was founded in 2012 and is headquartered in South San Francisco, California.
Medical Specialties Anatomy Sports Medicine Cardiomyopathy Muscular System
Is MYOK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 67.78
52 Week Low 39.01
Average Volume 496,504
200-Day Moving Average 52.4501
50-Day Moving Average 50.5112
20-Day Moving Average 48.2445
10-Day Moving Average 47.749
Average True Range 1.9151
ADX 15.09
+DI 24.6952
-DI 18.5365
Chandelier Exit (Long, 3 ATRs ) 45.5447
Chandelier Exit (Short, 3 ATRs ) 50.4203
Upper Bollinger Band 50.7059
Lower Bollinger Band 45.7831
Percent B (%b) 0.73
BandWidth 10.203857
MACD Line -0.3747
MACD Signal Line -0.6538
MACD Histogram 0.2791
Fundamentals Value
Market Cap 1.55 Billion
Num Shares 31.5 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -75.98
Price-to-Sales 26.88
Price-to-Book 9.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.01
Resistance 3 (R3) 51.06 50.57 50.74
Resistance 2 (R2) 50.57 50.16 50.55 50.65
Resistance 1 (R1) 49.98 49.90 49.74 49.93 50.56
Pivot Point 49.49 49.49 49.37 49.47 49.49
Support 1 (S1) 48.90 49.08 48.66 48.85 48.22
Support 2 (S2) 48.41 48.82 48.39 48.13
Support 3 (S3) 47.82 48.41 48.04
Support 4 (S4) 47.77